Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug;23(4):763-771.
doi: 10.1007/s12663-024-02251-z. Epub 2024 Jun 21.

Nano-Drug Carriers for Targeted Therapeutic Approaches in Oral Cancer: A Systematic Review

Vivekanand Kattimani  1 , Nom Kumar Naik Bhukya  2 , Gnana Sarita Kumari Panga  1 , Abhisikta Chakrabarty  3 , Prasanth Lingamaneni  4
Affiliations
Review

Nano-Drug Carriers for Targeted Therapeutic Approaches in Oral Cancer: A Systematic Review

Vivekanand Kattimani et al. J Maxillofac Oral Surg. 2024 Aug.

Abstract

Introduction: Nanotechnology has shown potential in treating different types of cancers. In particular, nano-drug delivery systems (DDSs) offer a promising strategy for treating oral cancer. By customizing therapy and improving drug delivery, these systems can improve outcomes for patients. Hence, a review was conducted to assess the current evidence and explore the use of DDSs for treating oral cancer.

Aim: To comprehensively explore the nano-drug carriers and target delivery for oral cancer therapy and to discuss the benefits, challenges, and potential to guide future research and clinical practice.

Methodology: A systematic search of articles archived in PubMed, Scopus, and Cochrane using keywords such as Nano, drug carrier, target drug delivery, and oral cancer was performed to fulfill the objectives from inception till February 2, 2024. Articles providing insights into nano-drug carriers in oral cancer were included.

Results: The results revealed a total of 156 articles. After duplicate removal, 136 articles were screened for title and abstract as per the inclusion and exclusion criteria. A total of 113 articles were excluded with reasons. Out of the remaining 23 articles, only 11 were included for qualitative data synthesis.

Conclusion: The literature revealed scarcity of oral cancer-related work using DDSs. Qualitative synthesis of data revealed that nano-drug carriers demonstrated a promising avenue for targeted therapeutic approaches in oral cancer, despite the challenges and their potential benefits. Continued research and development in this field are crucial to overcoming these challenges and fully realizing the potential of nano-drug carriers in revolutionizing oral cancer therapy.

Supplementary information: The online version contains supplementary material available at 10.1007/s12663-024-02251-z.

Keywords: Chemotherapy; Drug delivery; Management; Nanotechnology; Tumor.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestNone.

Figures

Fig. 1
Fig. 1
PRISMA 2020 flow diagram for systematic reviews on nano-drug carrier and delivery
See this image and copyright information in PMC

References

    1. Zhang M, Liang J, Yang Y et al (2020) Current Trends of targeted drug delivery for oral cancer therapy. Front Bioeng Biotechnol 8:618931 10.3389/fbioe.2020.618931 - DOI - PMC - PubMed
    1. Zhang Y, Wu Y, Du H et al (2024) Nano-drug delivery systems in oral cancer therapy: recent developments and prospective. Pharmaceutics 16:7. 10.3390/pharmaceutics16010007 10.3390/pharmaceutics16010007 - DOI - PMC - PubMed
    1. Mundekkad D, Cho WC (2022) Nanoparticles in clinical translation for cancer therapy. Int J Mol Sci 23:1685. 10.3390/ijms23031685 10.3390/ijms23031685 - DOI - PMC - PubMed
    1. He H, Liu L, Morin EE et al (2019) Survey of clinical translation of cancer nanomedicines—lessons learned from successes and failures. Acc Chem Res 52:2445–2461. 10.1021/acs.accounts.9b00228 10.1021/acs.accounts.9b00228 - DOI - PubMed
    1. Wang Z-Q, Liu K, Huo Z-J et al (2015) A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy. J Nanobiotechnology. 10.1186/s12951-015-0116-2 10.1186/s12951-015-0116-2 - DOI - PMC - PubMed

LinkOut - more resources